■ 英語タイトル：Veterinary Medicine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
	■ 発行会社/調査会社：IMARC ■ 商品コード：IMARC23JLY281 ■ 発行日：2023年7月 ■ 調査対象地域：グローバル ■ 産業分野：医療 ■ ページ数：142 ■ レポート言語：英語 ■ レポート形式：PDF ■ 納品方式：Eメール

Market Overview:

The global veterinary medicine market size reached US$ 33.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 49.4 Billion by 2028, exhibiting a growth rate (CAGR) of 6.5% during 2023-2028.

Veterinary medicine is a branch of science that deals in the prevention, control, diagnosis, and treatment of diseases that affect the health of domestic and wild animals. It helps maintain the health of food-producing animals, inhibit the transmission of zoonotic diseases from animal species to humans, and ensure a safe supply of food worldwide. At present, the escalating consumption of animal-derived products is increasing the adoption of veterinary medicines to monitor the health of agricultural animals and prevent human exposure to diseases.

Veterinary Medicine Market Trends:
The growing trend of nuclear families and inflating income levels have increased the overall spending of individuals on pets globally. This, in confluence with the rising concerns among pet parents about the well-being of their pets, represents one of the major factors supporting the demand for veterinary medicines. The increasing penetration of pet insurance is further influencing the market growth. Apart from this, the expanding animal husbandry activities, along with the escalating cases of zoonotic and chronic diseases among animals, are increasing the concerns about food safety. This, along with the increasing number of commercial animal-production programs, is promoting the adoption of veterinary medicines for better diagnosis and treatment for livestock. Moreover, the easy availability of advanced diagnostic imaging, novel therapies, nuclear and regenerative medicines, laser diagnostics, and specialized surgeries in numerous vet hospitals and clinics is bolstering the market growth. Furthermore, biomedical researchers are developing safe and effective vaccines to prevent pet diseases, which is anticipated to strengthen the market growth.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global veterinary medicine market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, animal type, route of administration and distribution channel.

Breakup by Product:
Drugs
Anti-infective
Anti-inflammatory
Parasiticide
Vaccines
Inactivated Vaccines
Attenuated Vaccines
Recombinant Vaccines
Medicated Feed Additives
Amino Acids
Antibiotics

Breakup by Animal Type:
Production
Companion

Breakup by Route of Administration:
Oral
Parenteral
Topical

Breakup by Distribution Channel:
Veterinary Hospitals and Clinics
Point-of-Care Testing/In-house Testing
Others

Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Archer-Daniels-Midland Company, Boehringer Ingelheim GmbH, Cargill Incorporated, Ceva Santé Animale, Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Evonik Industries AG, Merck & Co. Inc., Neogen Corporation, Vetoquinol S.A., Virbac and Zoetis Inc.

Key Questions Answered in This Report

1. What was the size of the global veterinary medicine market in 2022?
2. What is the expected growth rate of the global veterinary medicine market during 2023-2028?
3. What are the key factors driving the global veterinary medicine market?
4. What has been the impact of COVID-19 on the global veterinary medicine market?
5. What is the breakup of the global veterinary medicine market based on the animal type?
6. What is the breakup of the global veterinary medicine market based on the route of administration?
7. What is the breakup of the global veterinary medicine market based on the distribution channel?
8. What are the key regions in the global veterinary medicine market?
9. Who are the key players/companies in the global veterinary medicine market?

■ 英語タイトル：Vascular Stents Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
	■ 発行会社/調査会社：IMARC ■ 商品コード：IMARC23JLY280 ■ 発行日：2023年7月 ■ 調査対象地域：グローバル ■ 産業分野：医療 ■ ページ数：142 ■ レポート言語：英語 ■ レポート形式：PDF ■ 納品方式：Eメール

Market Overview:

The global vascular stents market size reached US$ 10.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 14.3 Billion by 2028, exhibiting a growth rate (CAGR) of 6.1% during 2023-2028.

A vascular stent is a small device that is used to clear and prevent blockages in the heart valves and arteries. It is also used to provide internal structural support to stenotic or occluded blood vessels. The process of placing a vascular stent inside the body is known as vascular stenting. Vascular stents are usually made of polyethylene, polypropylene or non-absorbable materials such as stainless steel or cobalt-chromium alloys. They may vary from tubular stent-grafts, which are used to repair aneurysms, to expandable metal meshes that are used during percutaneous vessel interventions. Once the stent is placed in the intended location, it is expanded using a balloon or a self-expanding mechanism.

Rapidly increasing geriatric population is one of the major factors driving the market growth worldwide. Furthermore, there has been a rise in the incidence rate of various ailments such as peripheral artery disease (PAD), aortic aneurysm, and ischemic heart disease. The frequent occurrence of these ailments has led to a growing requirement for vascular stents. This can be attributed to lifestyle choices such as smoking and high alcohol consumption coupled with physical inactivity and unhealthy dietary habits of individuals. Additionally, increasing consumer inclination toward minimally invasive (MI) procedures is also driving the market growth. The MI vascular stenting procedures ensure shorter hospital stay, quick recovery and greater comfort for the patients. Moreover, the emerging trend of peripheral and endovascular aneurysm repair (EVAR) stent grafting is also contributing to the market growth. The EVAR is widely preferred for patients with advanced age and renal dysfunction, while peripheral stenting is done to provide support to femoropopliteal and infrapopliteal arteries above the knee.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global vascular stents market report, along with forecasts at the global and regional level from 2023-2028. Our report has categorized the market based on product type, material, mode of delivery and end-user.

Breakup by Product Type:
Coronary Stents
Peripheral Vascular Stents
Evar Stent Grafts

Breakup by Material:
Metallic Stents
Cobalt Chromium
Platinum Chromium
Nickel Titanium
Stainless Steel
Others

Breakup by Mode of Delivery:
Balloon-Expandable Stents
Self-Expanding Stents

Breakup by End-User:
Hospitals and Cardiac Centers
Ambulatory Surgical Centers

Breakup by Region:
North America
Europe
Asia Pacific
Middle East and Africa
Latin America

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Medtronic Plc, Abbott Laboratories, Boston Scientific Corporation, Biotronik Se & Co. Kg, Braun Melsungen Ag, Terumo Corporation, Microport Scientific Corporation, Meril Life Sciences Pvt. Ltd., Vascular Concepts Limited, C.R. Bard, Inc., W.L. Gore and Associates, Inc., Endologix, Inc., Lombard Medical, Translumina Gmbh, Jotec Gmbh, etc.

Key Questions Answered in This Report:

How has the global vascular stents market performed so far and how will it perform in the coming years?
What are the key regional markets in the global vascular stents industry?
What has been the impact of COVID-19 on the global vascular stents industry?
What is the breakup of the market based on the product type?
What is the breakup of the market based on the material?
What is the breakup of the market based on the mode of delivery?
What is the breakup of the market based on the end-user?
What are the various stages in the value chain of the global vascular stents industry?
What are the key driving factors and challenges in the global vascular stents industry?
What is the structure of the global vascular stents industry and who are the key players?
What is the degree of competition in the global vascular stents industry?
What are the profit margins in the global vascular stents industry?

■ 英語タイトル：Varicose Vein Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
	■ 発行会社/調査会社：IMARC ■ 商品コード：IMARC23JLY279 ■ 発行日：2023年7月 ■ 調査対象地域：グローバル ■ 産業分野：医療 ■ ページ数：140 ■ レポート言語：英語 ■ レポート形式：PDF ■ 納品方式：Eメール

Market Overview:

The global varicose vein treatment market size reached US$ 415.6 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 579.5 Million by 2028, exhibiting a growth rate (CAGR) of 5.4% during 2023-2028.

Varicose vein treatment comprises self-care measures, compression stockings, and surgeries, such as sclerotherapy, laser treatment, catheter-based radiofrequency, high ligation and vein stripping, and ambulatory phlebectomy. It assists in treating twisted and enlarged veins that are close to the surface of the skin. It also helps reduce ache or heavy feeling in the legs, worsened pain after sitting or standing for a long time, itching around one or more of the veins, changes in skin color around varicose veins, and burning, throbbing, muscle cramping and swelling in the lower legs. As a result, it finds applications in hospitals, clinics, and ambulatory centers worldwide.

Varicose Vein Treatment Market Trends:
Presently, the rising prevalence of varicose vein problems among individuals, along with the growing geriatric population, represents one of the key factors driving the market across the globe. Moreover, there is an increase in the advancement of varicose vein treatment devices. This, coupled with the burgeoning healthcare industry, is propelling the growth of the market. In addition, the growing adoption of minimally invasive treatment procedures due to less postoperative pain, fewer operative and major postoperative complications, shortened hospital stay, and faster recovery times is positively influencing the market around the world. Besides this, the rising awareness among individuals about the treatment is offering lucrative growth opportunities to industry investors. Apart from this, key market players are extensively investing in research and development (R&D) activities to introduce advanced equipment, such as varithena and VenaSeal closure systems. In line with this, the increasing obesity among individuals due to changing lifestyles and lack of exercise is catalyzing the demand for varicose vein treatment. Other growth-inducing factors are technological advancements, prolonged standing hours at work, and excessive smoking.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global varicose vein treatment market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, procedure and end user.

Breakup by Product:
Ablation Devices
Radiofrequency Ablation Devices
Laser Ablation Devices
Others
Sclerotherapy Injection
Others

Breakup by Procedure:
Injection Sclerotherapy
Endovenous Ablation
Surgical Ligation and Stripping

Breakup by End User:
Hospitals
Clinics
Ambulatory Centers

Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Alma Lasers Ltd. (Sisram Medical Ltd.), Angiodynamics Inc., Biolitec AG (BioMed Technology Holdings Ltd.), Boston Scientific Corporation, Eufoton S.R.L., Fotona, Medtronic plc, Sciton Inc., Teleflex Incorporated, The Vein Company, VVT Medical Ltd. and WON TECH Co. Ltd.

Key Questions Answered in This Report:
How has the global varicose vein treatment market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global varicose vein treatment market?
What are the key regional markets?
What is the breakup of the market based on the product?
What is the breakup of the market based on the procedure?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global varicose vein treatment market and who are the key players?
What is the degree of competition in the industry?

■ 英語タイトル：Vacuum Ovens Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
	■ 発行会社/調査会社：IMARC ■ 商品コード：IMARC23JLY277 ■ 発行日：2023年7月 ■ 調査対象地域：グローバル ■ 産業分野：医療 ■ ページ数：139 ■ レポート言語：英語 ■ レポート形式：PDF ■ 納品方式：Eメール

Market Overview 2023-2028:

The global vacuum ovens market size reached US$ 234.3 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 343.2 Million by 2028, exhibiting a growth rate (CAGR) of 6.38% during 2023-2028.

A vacuum oven is an extremely versatile equipment that has applications in laboratory research, engineering, and industry. In vacuum ovens, the process of heat treatment takes place inside an airtight vessel. This enables a vacuum to be drawn inside the vessel. The entire heat-treating procedure can be initiated under vacuum or precisely controlled environments can be introduced. Heat treating under vacuum can provide numerous advantages such as:

It can prevent surface reactions like oxidation or decarburization
It can remove surface contaminants like oxide films and residual traces of lubricants
It can add a substance to the surface layers of the work
It can remove dissolved contaminating materials from metals by degassing

The rise of the vacuum oven market largely relies on the legalised use of cannabis in considerable parts of the world and the commercialisation that materializes with it. For the legalised cannabis growers, vacuum ovens help them to process cannabis extract BHOs (Butane Hash oil). Through these vacuums, the growers get purified oil extract, along with a reduced risk of fire while performing the entire process. The vacuum ovens are also used in the medical industry to remove chemicals that are possibly toxic to the human body. This process is essentially compelling for embedded medical devices like artificial heart valves, pacemakers and even joints. In addition to this, these ovens are also used in order to comprehend how a device will react to the high vacuum environment of space, which makes them a viable equipment for the aerospace industry.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global vacuum ovens market report, along with forecasts at the global and regional level from 2023-2028. Our report has categorized the market based on product type and application.

Breakup by Product Type:
<200 200-300 >300

Based on the product type, the market has been segmented into <200, 200-300 and >300.

Breakup by Application:
Home Appliances
Commercial Appliances

Based on the application, the market has been segmented into home appliances and commercial appliances.

Regional Insights:
North America
Europe
Asia Pacific
Middle East and Africa
Latin America

Region-wise, the market has been segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Competitive Landscape:
The competitive landscape of the market has also been examined with some of the key players being Cole-Parmer, Memmert GmbH+Co.KG, MTI Corporation, Sheldon Manufacturing Inc, Thermo Fisher Scientific, Accumax India, BINDER GmbH, Cascade TEK, ESPEC, Grieve, JEIO, SalvisLab Renggli, Shanghai Hasuc Instrument, Ted Pella and Yamato Scientific.

This report provides a deep insight into the global vacuum ovens market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the vacuum ovens industry in any manner.

Key Questions Answered in This Report:
How has the global vacuum ovens market performed so far and how will it perform in the coming years?
What are the key regional markets in the global vacuum ovens industry?
What has been the impact of COVID-19 on the global vacuum ovens industry?
What is the breakup of the global vacuum ovens market on the basis of product type?
What is the breakup of the global vacuum ovens market on the basis of application?
What are the price trends of vacuum ovens?
What are the various stages in the value chain of the global vacuum ovens market?
What are the key driving factors and challenges in the global vacuum ovens market?
What is the structure of the global vacuum ovens market and who are the key players?
What is the degree of competition in the global vacuum ovens market?
How are vacuum ovens manufactured?

■ 英語タイトル：Tumor Ablation Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
	■ 発行会社/調査会社：IMARC ■ 商品コード：IMARC23JLY274 ■ 発行日：2023年7月 ■ 調査対象地域：グローバル ■ 産業分野：医療 ■ ページ数：144 ■ レポート言語：英語 ■ レポート形式：PDF ■ 納品方式：Eメール

Market Overview:

The global tumor ablation market size reached US$ 1,050 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 2,110 Million by 2028, exhibiting a growth rate (CAGR) of 12.3% during 2023-2028.

Tumor ablation refers to a minimally invasive (MI) technique that is conducted to treat tumors of the kidney, liver, bones and lungs. The ablation system consists of a generator and a needlelike device that delivers the heat directly to the target cells to cause acute cellular necrosis. The procedure destroys benign tumors by inserting a probe and heating it to 100-degree Celsius under Precise Computer Tomography, without extracting them from the body. It can be conducted through Microwave Ablation, Radiofrequency Ablation, Cryoablation, etc. It provides increased accuracy and covers a larger treatment area, along with minimal pain and risk to the patient upon repeated administrations.

The increasing prevalence of cancer is one of the key factors driving the growth of the market. Furthermore, owing to benefits such as the lesser amount of trauma, speedy recovery, reduced complications and shorter hospital stay, MI procedures are gaining widespread preference, which, in turn, is driving the market growth. Also, various technological advancements such as the introduction of thermal and laser ablation, irreversible electroporation and High-Intensity Focused Ultrasound (HIFU) have enhanced the acceptance of tumor ablation procedures. Moreover, the implementation of favorable government policies for cancer awareness and treatment methods is also creating a positive outlook for the market. Other factors driving the market include growing healthcare expenditures and rising geriatric population, along with the increasing number of ablation and surgical centers and awareness for ablation procedures that can be conducted over small tumors.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global tumor ablation market report, along with forecasts at the global and regional level from 2023-2028. Our report has categorized the market based on technology, mode of treatment, mode of application and end-user.

Breakup by Technology:
Radiofrequency (RF) Ablation
Microwave Ablation
Cryoablation
Others

Breakup by Mode of Treatment:
Percutaneous Ablation
Laparoscopic Ablation
Surgical Ablation

Breakup by Mode of Application:
Liver Cancer
Lung Cancer
Kidney Cancer
Bone Metastasis
Others

Breakup by End-User:
Hospitals
Cancer Specialty Clinics
Others

Breakup by Region:
North America
Europe
Asia Pacific
Middle East and Africa
Latin America

Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Medtronic Public Limited Company, AngioDynamics, Inc., HealthTronics, Inc., NeuWave Medical, Inc., INTIO, Inc., Galil Medical Ltd., Boston Scientific Corporation, SonaCare Medical, LLC, EDAP TMS S.A., Erbe Elektromedizin GmbH, IceCure Medical Ltd., MISONIX Inc., Endocare Inc., CooperSurgical Inc. and B V M Meditech Pvt.

Key Questions Answered in This Report

1. What was the size of the global tumor ablation market in 2022?
2. What is the expected growth rate of the global tumor ablation market during 2023-2028?
3. What has been the impact of COVID-19 on the global tumor ablation market?
4. What are the key factors driving the global tumor ablation market?
5. What is the breakup of the global tumor ablation market based on the technology?
6. What is the breakup of the global tumor ablation market based on the mode of treatment?
7. What is the breakup of the global tumor ablation market based on mode of application?
8. What is the breakup of the global tumor ablation market based on the end-user?
9. What are the key regions in the global tumor ablation market?
10. Who are the key players/companies in the global tumor ablation market?

■ 英語タイトル：Traditional Wound Management Market Report by Product (Gauze, Tape, Bandages, Cotton), Application (Chronic Wounds, Acute Wounds), End User (Hospitals and Clinics, Home Healthcare, Ambulatory Surgical Centers, and Others), and Region 2023-2028
	■ 発行会社/調査会社：IMARC ■ 商品コード：IMARC23JLY272 ■ 発行日：2023年7月 ■ 調査対象地域：グローバル ■ 産業分野：医療 ■ ページ数：141 ■ レポート言語：英語 ■ レポート形式：PDF ■ 納品方式：Eメール

Market Overview:

The global traditional wound management market size reached US$ 5.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 7.1 Billion by 2028, exhibiting a growth rate (CAGR) of 4.30% during 2023-2028. The rising prevalence of chronic and acute wounds, the increasing number of surgical procedures, escalating incidences of fatal road accidents, and ongoing improvements in healthcare infrastructure represent some of the key factors driving the market.

Traditional wound management refers to the use of various wound care products, such as clinical dressings, cotton pads, and gauzes, to clean the wound, promote faster healing, and stop bleeding. It aids in absorbing wound fluids, managing and preventing infections, controlling mechanical influences, and improving collagen maturation. It also assists in protecting the wound from contamination and is generally preferred for acute and chronic wounds with mild exudate levels and employed as primary or secondary dressings. It is widely used to manage a range of chronic wounds, such as surgical incisions, diabetic foot ulcers, pressure ulcers, venous leg ulcers, and arterial ulcers. As a result, traditional wound management finds extensive applications in healthcare settings for treating burns, trauma, injuries, and surgical wounds across the globe.

Traditional Wound Management Market Trends:
The rising instances of acute wounds and minor injuries represent one of the key factors supporting the market growth. Moreover, the increasing number of surgical procedures across the globe has generated the need for traditional wound management products to prevent surgical-site infections (SSIs), improve treatment outcomes, enhance patient care, and reduce the duration of hospital stays. This can be attributed to the high prevalence of chronic diseases, such as urological disorders, cancer, cardiovascular diseases (CVDs), neurovascular conditions, obesity, and diabetes, due to smoking habits, sedentary lifestyles, and excessive alcohol consumption. Besides this, a surge in the establishment of ambulatory surgical centers (ASCs) and the escalating incidences of fatal road accidents have catalyzed product demand. In addition, the rising adoption of advanced wound care practices in ambulatory and outpatient centers is augmenting the market growth. In line with this, the widespread availability of favorable reimbursement policies and heavy investments by governments of various countries in improving healthcare infrastructure has propelled market growth. Furthermore, ongoing product innovations by key players, such as the launch of spray and smart bandages, new topical ointments, and design variations in adhesive bandages, are driving the market toward growth. Other factors, including the expanding geriatric population, increasing adoption of minimally invasive (MI) cosmetic procedures, emerging home healthcare trends, inflating consumer healthcare spending, and extensive research and development (R&D) activities, are also anticipated to provide a positive thrust to the market growth.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global traditional wound management market, along with forecasts at the global, regional, and country levels from 2023-2028. Our report has categorized the market based on product, application, and end user.

Product Insights:
Gauze
Tape
Bandages
Cotton

The report has provided a detailed breakup and analysis of the traditional wound management market based on the product. This includes gauze, tape, bandages, and cotton. According to the report, gauze represented the largest segment.

Application Insights:
Chronic Wounds
Acute Wounds

A detailed breakup and analysis of the traditional wound management market based on the application has also been provided in the report. This includes chronic wounds and acute wounds. According to the report, acute wounds accounted for the largest market share.

End User Insights:
Hospitals and Clinics
Home Healthcare
Ambulatory Surgical Centers
Others

The report has provided a detailed breakup and analysis of the traditional wound management market based on the end user. This includes hospitals and clinics, home healthcare, ambulatory surgical centers, and others.

Regional Insights:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for traditional wound management. Some of the factors driving the North America traditional wound management market included its aging population, growing burden of cancer, high healthcare expenditure, rising number of ASCs in the region, etc.

Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global traditional wound management market. Detailed profiles of all major companies have been provided. Some of the companies covered include B. Braun Melsungen AG, Cardinal Health Inc., Datt Mediproducts Pvt Ltd., DeRoyal Industries Inc., Dukal LLC, Essity AB, Medtronic plc, Mölnlycke Health Care AB, Paul Hartmann AG, Smith & Nephew plc, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:
How has the global traditional wound management market performed so far, and how will it perform in the coming years?
What are the drivers, restraints, and opportunities in the global traditional wound management market?
What is the impact of each driver, restraint, and opportunity on the global traditional wound management market?
What are the key regional markets?
Which countries represent the most attractive traditional wound management market?
What is the breakup of the market based on the product?
Which is the most attractive product in the traditional wound management market?
What is the breakup of the market based on the application?
Which is the most attractive application in the traditional wound management market?
What is the breakup of the market based on the end user?
Which is the most attractive end user in the traditional wound management market?
What is the competitive structure of the global traditional wound management market?
Who are the key players/companies in the global traditional wound management market?

■ 英語タイトル：Synthetic Biology Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
	■ 発行会社/調査会社：IMARC ■ 商品コード：IMARC23JLY265 ■ 発行日：2023年7月 ■ 調査対象地域：グローバル ■ 産業分野：医療 ■ ページ数：141 ■ レポート言語：英語 ■ レポート形式：PDF ■ 納品方式：Eメール

Market Overview:

The global synthetic biology market size reached US$ 13.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 38.8 Billion by 2028, exhibiting a growth rate (CAGR) of 18.1% during 2023-2028.

Synthetic biology refers to a field of research involving the construction and designing of new biological entities, such as enzymes, genetic circuits, and cells or redesigning organisms for valuable purposes by engineering them to have unique abilities. It combines the chemical synthesis of deoxyribonucleic acid (DNA) with genomics to enable researchers to manufacture cataloged DNA sequences and assemble them into new genomes. It assists in improving the environment by discovering novel ways to reduce pollution, making industrial processes for chemical synthesis sustainable, and removing the need for damaging farming practices by making better fertilizers.

Synthetic Biology Market Trends:
In recent years, improvements in the speed and cost of DNA synthesis have enabled scientists in designing and synthesizing modified bacterial chromosomes, which can be utilized in the production of advanced biofuels, bio-products, renewable chemicals, and bio-based specialty chemicals. This, in confluence with increasing investments in synthetic biology, represents one of the key factors impelling the growth of the market. Moreover, synthetic biology is employed in the healthcare sector as it can help improve diagnosis and develop better treatment options for numerous diseases, directed only towards the site of disease without causing any adverse effects. Besides this, there is a significant rise in the use of genetically engineered viruses to correct defective genes in patients with inherited diseases like epidermolysis bullosa or severe combined immune deficiency (SCID). Apart from this, tools for performing synthetic biology are becoming more accessible, and the internet penetration has enabled ideas and information to be freely exchanged, which is facilitating the market growth. Furthermore, significant growth in the healthcare sector and the rising number of synthetic biology research entities worldwide are positively influencing the market.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global synthetic biology market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, technology and application.

Breakup by Product:
Oligonucleotide/Oligo Pools and Synthetic DNA
Enzymes
Cloning Technologies Kits
Xeno-nucleic Acids
Chassis Organism

Breakup by Technology:
NGS Technology
PCR Technology
Genome Editing Technology
Bioprocessing Technology
Others

Breakup by Application:
Healthcare
Clinical
Non-Clinical/Research
Non-Healthcare
Biotech Crops
Specialty Chemicals
Bio-Fuels
Others

Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Agilent Technologies Inc., Amyris Inc., Codexis Inc., Danaher Corporation, Eurofins Scientific, GenScript Biotech Corporation, Illumina Inc., Merck KGaA, New England Biolabs, Synthego Corporation, Thermo Fisher Scientific Inc., Twist Bioscience and Viridos Inc.

Key Questions Answered in This Report:
How has the global synthetic biology market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global synthetic biology market?
What are the key regional markets?
What is the breakup of the market based on the product?
What is the breakup of the market based on the technology?
What is the breakup of the market based on the application?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global synthetic biology market and who are the key players?
What is the degree of competition in the industry?